Tin tức/Reuters/Curevac and GSK agree to resolve patent dispute litigation with Pfizer and BioNTechCurevac and GSK agree to resolve patent dispute litigation with Pfizer and BioNTechRefinitivThời gian đọc: dưới 1 phútCVACGSKPFEBNTXCurevac CVAC said on Thursday that the company and GSK GSK have entered an agreement to resolve patent dispute with Pfizer PFE and BioNTech BNTX over mRNA-based COVID-19 vaccines. Châu ÂuChứng khoán Hoa KỳReuters© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.htmlHiển thị thêmĐăng nhập hoặc tạo tài khoản miễn phí trọn đời để đọc tin tức nàyBắt đầu
